XOMA (NASDAQ:XOMAP – Get Free Report) is expected to issue its resultson Thursday, July 30th. Analysts expect the company to announce earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Stock Performance
NASDAQ:XOMAP opened at $24.98 on Tuesday. The firm has a 50-day moving average price of $25.27 and a two-hundred day moving average price of $25.77. XOMA has a twelve month low of $24.93 and a twelve month high of $30.00.
XOMA Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a dividend of $0.5391 per share. This represents a $2.16 annualized dividend and a dividend yield of 8.6%. The ex-dividend date was Thursday, July 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Recommended Stories
- Five stocks we like better than XOMA
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
